 Connection
Emily Muther to Cystic Fibrosis
This is a "connection" page, showing publications Emily Muther has written about Cystic Fibrosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.824 |
|
|
|
-
Muther EF, Gibson SL, Ford C, Duncan C, Riekert KA, Lyons E, Hoppe JE, Prickett M, Isenburg MV, Everhart RS. People with cystic fibrosis' experience of symptom burden while taking elexacaftor/tezacaftor/ivacaftor. Respir Med. 2026 Aug; 259:108908.
Score: 0.468
-
Lyons ER, Vigers T, Simoni M, Lynn C, Muther E. Body Image Perceptions and Elexacaftor/Tezacaftor/Ivacaftor (ETI) Use in Adolescents and Young Adults Living With Cystic Fibrosis. Pediatr Pulmonol. 2025 Dec; 60(12):e71418.
Score: 0.452
-
Muther EF, Polineni D, Sawicki GS. Overcoming psychosocial challenges in cystic fibrosis: Promoting resilience. Pediatr Pulmonol. 2018 11; 53(S3):S86-S92.
Score: 0.271
-
Duncan CL, von Isenburg M, Green A, Ford C, Pucci A, Muther EF, Riekert KA, Bord E, Hoppe JE, Bacon C, Goodman A, Lyons E, Prickett M, Gibson SL, Everhart RS. Caregiver Mental Health and Its Relation to Child and Adolescent Mental and Behavioral Health in the Era of Highly Effective Modulator Therapy for Cystic Fibrosis. Pediatr Pulmonol. 2026 Aug; 61(8):e71794.
Score: 0.118
-
Quittner AL, Seng E, Smith BA, Graziano S, Chaudhary N, Lomas P, Muther E, Schechter MS, Tillman L, Toth C, Verkleij M, Wei R, Georgiopoulos AM. The Human Cost of Respiratory Care: Professional Quality of Life and Burnout Across Multidisciplinary Cystic Fibrosis Teams. Chest. 2026 Aug; 170(2):338-352.
Score: 0.115
-
Everhart RS, Saavedra MT, Ford CR, Gibson SL, Reid F, Muther EF, Duncan CL, Cravens R, Green A, Riekert KA. Mental health and adherence in CF: Self-efficacy and perceived barriers as mediators. J Cyst Fibros. 2025 03; 24(2):334-340.
Score: 0.107
-
Lyons ER, Muther E, Sabharwal S. Nutrition and behavioral health in cystic fibrosis: Eating and body image. Pediatr Pulmonol. 2024 Sep; 59 Suppl 1:S36-S43.
Score: 0.104
-
Bathgate CJ, Muther E, Georgiopoulos AM, Smith B, Tillman L, Graziano S, Verkleij M, Lomas P, Quittner A. Positive and negative impacts of elexacaftor/tezacaftor/ivacaftor: Healthcare providers' observations across US centers. Pediatr Pulmonol. 2023 09; 58(9):2469-2477.
Score: 0.095
-
Quittner AL, Barker D, Graziano S, Georgiopoulos AM, Muther E, Verkleij M, Schechter MS, Tillman L, Mueller A, Lomas P, Hempstead S, Smith BA. National integration of mental health screening and treatment into specialized care for cystic fibrosis: What predicts success? Pediatr Pulmonol. 2023 06; 58(6):1768-1776.
Score: 0.094
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|